InnovAge Holding Corp. (INNV)
USD 3.75
(-8.09%)
USD 3.75
(-8.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 247.85 Million USD | -1.86% |
| 2023 | 252.55 Million USD | 25.12% |
| 2022 | 201.85 Million USD | 16.15% |
| 2021 | 173.78 Million USD | -42.43% |
| 2020 | 301.88 Million USD | 7.13% |
| 2019 | 281.79 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 247.85 Million USD | 8.22% |
| 2024 Q3 | 229.03 Million USD | -0.98% |
| 2024 Q2 | 231.29 Million USD | -3.85% |
| 2024 FY | 247.85 Million USD | -1.86% |
| 2024 Q1 | 240.54 Million USD | -4.76% |
| 2023 Q3 | 243.76 Million USD | 13.73% |
| 2023 Q2 | 214.34 Million USD | -12.06% |
| 2023 FY | 252.55 Million USD | 25.12% |
| 2023 Q1 | 243.72 Million USD | 20.74% |
| 2023 Q4 | 252.55 Million USD | 3.61% |
| 2022 Q2 | 189.56 Million USD | 7.51% |
| 2022 Q4 | 201.85 Million USD | 5.09% |
| 2022 Q3 | 192.06 Million USD | 1.32% |
| 2022 Q1 | 176.32 Million USD | 1.46% |
| 2022 FY | 201.85 Million USD | 16.15% |
| 2021 Q2 | 405.99 Million USD | 0.0% |
| 2021 FY | 173.78 Million USD | -42.43% |
| 2021 Q4 | 173.78 Million USD | -3.63% |
| 2021 Q3 | 180.33 Million USD | -55.58% |
| 2020 Q4 | 301.88 Million USD | 0.0% |
| 2020 FY | 301.88 Million USD | 7.13% |
| 2019 FY | 281.79 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 89.97% |
| Addus HomeCare Corporation | 317.73 Million USD | 21.993% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -91.304% |
| Amedisys, Inc. | 940.38 Million USD | 73.644% |
| American Oncology Network, Inc. | 368.72 Million USD | 32.781% |
| Astrana Health, Inc. | 522.59 Million USD | 52.572% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 85.954% |
| IMAC Holdings, Inc. | 1.89 Million USD | -12967.136% |
| biote Corp. | 191.84 Million USD | -29.197% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -243.04% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -20.361% |
| COMPASS Pathways plc | 50.24 Million USD | -393.309% |
| DocGo Inc. | 185.28 Million USD | -33.771% |
| The Ensign Group, Inc. | 2.68 Billion USD | 90.753% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 28.483% |
| Assure Holdings Corp. | 22.84 Million USD | -984.743% |
| The Joint Corp. | 62.37 Million USD | -297.334% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 69.183% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -6403.345% |
| ModivCare Inc. | 1.61 Billion USD | 84.616% |
| NewGenIvf Group Limited | 1.24 Million USD | -19865.04% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -2140.181% |
| Option Care Health, Inc. | 1.9 Billion USD | 87.001% |
| P3 Health Partners Inc. | 427.3 Million USD | 41.996% |
| P3 Health Partners Inc. | 427.3 Million USD | 41.996% |
| The Pennant Group, Inc. | 394.17 Million USD | 37.121% |
| Surgery Partners, Inc. | 3.65 Billion USD | 93.223% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -27134.439% |
| Talkspace, Inc. | 23.57 Million USD | -951.338% |
| Talkspace, Inc. | 23.57 Million USD | -951.338% |
| The Oncology Institute, Inc. | 162.39 Million USD | -52.625% |
| The Oncology Institute, Inc. | 162.39 Million USD | -52.625% |